FloraWorks Announces Peer-Reviewed Publication of Groundbreaking Sleep Study on TruCBN(TM)
TruCBN(TM) is the first cannabinoid proven to be a safe and effective sleep aid in the largest blinded, randomized, placebo-controlled...
Pharmaceutical
PureHealth Achieves AED 1.0 billion Net Profit in 1H 2024; EBITDA Soars to AED 2.2 billion
PureHealth booked a 53% y-o-y increase in revenue to AED 12.5 billion in H1 2024 following solid growth across its...
Cosmo Intelligent Medical Devices Unveils Next Generation GI Genius(TM) Hardware with New FDA Clearance
Dublin, Ireland--(Newsfile Corp. - July 31, 2024) - Cosmo Intelligent Medical Devices (Cosmo IMD), a division of Cosmo Pharmaceuticals N.V....
Medexus Schedules First Fiscal Quarter 2025 Conference Call
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - July 30, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host...
inPhronesis Announces Name Change to inThought Labs
The new name highlights the combined capabilities of decision support expertise and advanced technology solutions ORLANDO, Fla., July 30, 2024...
Clinical Trial Management System (CTMS) Market size is set to grow by USD 1.86 billion from 2024-2028, Increasing healthcare expenditure to boost the market growth, Technavio
NEW YORK, July 30, 2024 /PRNewswire/ -- The global clinical trial management system (CTMS) market size is estimated to grow by...
Near-Infrared (NIR) Spectroscopy Market size is set to grow by USD 698.9 million from 2024-2028, Rising food safety concerns boost the market, Technavio
NEW YORK, July 30, 2024 /PRNewswire/ -- The global near-infrared (NIR) spectroscopy market size is estimated to grow by USD 698.9 million...
Agilisium Achieves AWS Life Sciences Competency Status
LOS ANGELES, July 30, 2024 /PRNewswire/ -- Agilisium, a pioneering leader in Data Analytics, Cloud, and Life Science solutions, today announced...
eClinical Solutions Market worth $22.1 billion by 2029 driven by Rising Chronic Illness Rates | MarketsandMarkets™
CHICAGO, July 30, 2024 /PRNewswire/ -- The global eClinical Solutions Market is expected to grow from USD 11.6 billion in 2024...
Next Presentation in Record-Breaking Sleep Apnea Webinar Series Announced
Live presentations by leading sleep researchers available globally to front-line clinicians MURFREESBORO, Tenn., July 30, 2024 /PRNewswire/ -- SleepWorld Magazine...
Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities
BURLINGTON, N.C., and FREMONT, Calif., July 29, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive...
RevHealth Announces First Pharma-Optimized AI Agency Platform
MORRISTOWN, N.J., July 30, 2024 /PRNewswire/ -- RevHealth, a full-service independent pharmaceutical marketing and communications agency, has announced the launch...
Prostate Cancer Foundation Canada Announces Leadership Transition
Dr. Abby C. Collier will take over from Leah Lariviere as Executive Director, effective August 1, 2024Vancouver, British Columbia--(Newsfile Corp....
Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential
NEW YORK and SANTA BARBARA, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Phytanix Bio, a pioneering preclinical stage pharmaceutical company...
AGAPE ATP Corporation Strengthens Wellness Division via Innovative Incubation with Emerging Local SMEs
Expanding Elderly Care and Wellness Services with collaboration projects in the Pain Management Market and Elderly Care Solutions Market KUALA...
Envision Pharma Group Announces the Appointment of Bill Shirey to President of Life Science Commercialization
FAIRFIELD, CT / ACCESSWIRE / July 30, 2024 / Envision Pharma Group (Envision) announced today the appointment of Bill Shirey...
CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies
Strategic in-license from Cortice Bioscience is highly synergistic with the ongoing potentially pivotal Berubicin program and demonstrates further commitment to...
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in August
NORWOOD, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced...
Evoke Pharma, Inc. Announces Reverse Stock Split
SOLANA BEACH, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily...
Yamo Pharmaceuticals Announces Positive Topline Results from Phase 2 Study of L1-79 for the Treatment of the Core Symptoms of Autism
Data shows L1-79 offers a statistically significant improvement compared to placebo in socialization, as well as the investigator- and parent-rated...